LONDON, May 11, 2023 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, reported its financial results for the first quarter 2023 and gave an update on recent progress across its business. Kabir Nath, Chief Executive Officer, said, “Our phase 3 pivotal trials in…

Source

Previous articleMIND CURE CLOSES PREVIOUSLY ANNOUNCED PRIVATE PLACEMENT
Next articleTerran Biosciences announces publication of four PCT patent applications covering breakthroughs in novel empathogens, including improved versions of methylone, ethylone, MDEA, MDAI, and MBDB